Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/16/2025

Lymph Node Assessment Guidelines

Benign Features

  • The presence of a central intranodal vessel pattern (Nakajima grade 0-1) is consistently benign, with a preserved fatty hilum being the single most important benign feature in lymph node assessment, having 96-100% specificity for excluding metastatic disease 1, 2, 3, 4
  • A fatty hilum itself has high negative predictive value for malignancy, according to the American College of Radiology 4, 5

Malignant Features

  • Malignant hypervascularity manifests as peripheral/cortical vessels with rich flow involving >4 vessels (Nakajima grades 2-3), carrying 87.7% sensitivity and 69.6% specificity for malignancy 1, 2, 3
  • Loss of central hilar structure, often accompanied by cortical thickening >3mm, is a concerning feature for malignancy 3, 4, 6

Size and Surveillance

  • Lymph nodes ≤15mm in short axis consistently demonstrate reactive or benign pathology, but size becomes less predictive when a fatty hilum is preserved 1, 2, 3, 4
  • Short-interval ultrasound follow-up in 4-6 weeks is appropriate to document stability or resolution, confirming the reactive nature 4, 5

Clinical Context and Escalation

  • In a young adult with no significant medical history and no systemic symptoms, reactive lymphadenopathy is far more likely than lymphoma 5
  • The National Comprehensive Cancer Network recommends observation and monitoring as the standard approach for reactive lymphadenopathy 5
  • Biopsy should be pursued if there is loss of fatty hilum, progressive enlargement, development of irregular borders, necrosis, or extranodal extension, or new systemic B symptoms 4, 5, 6